Lifevantage Corporation (LFVN)

Currency in USD
13.090
+0.150(+1.16%)
Closed·
After Hours
13.0900.000(0.00%)
·
LFVN Scorecard
Full Analysis
Management has been aggressively buying back shares
LFVN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
12.56613.205
52 wk Range
7.09027.380
Key Statistics
Prev. Close
13.09
Open
13.09
Day's Range
12.566-13.205
52 wk Range
7.09-27.38
Volume
67.42K
Average Volume (3m)
150.32K
1-Year Change
72.46%
Book Value / Share
2.71
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LFVN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
18.000
Upside
+37.51%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Lifevantage Corporation News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Lifevantage Corporation Company Profile

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, and skin and hair care products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement designed to strengthen immune health; LifeVantage Rise AM & Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3, vitamin K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; PhysIQ Fat Burn to support weight management; PhysIQ Prebiotic is a dietary supplement designed to support the good bacteria in the gut and a healthy microbiome; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. The company also provides anti-aging skin care products, including liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, hand creams, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and the Philippines. The company also launch Evolve Compensation Plan and other LV360 initiatives into the Philippines, Taiwan, Hong Kong, and Singapore. The company is based in Lehi, Utah.

Employees
222

Lifevantage Corporation Earnings Call Summary for Q3/2025

  • Q3 2025 EPS of $0.26 beat $0.20 forecast; revenue of $58.4M missed $60.99M estimate. Stock fell 21.47% after hours to $9.40.
  • Revenue up 21.1% YoY, driven by 29.5% growth in Americas. Asia Pacific and Europe declined 7.2%. Adjusted EBITDA rose 27% to $6.4M.
  • FY2025 guidance: Revenue $228-235M (16% YoY growth), adjusted EBITDA $21-24M, adjusted EPS $0.72-$0.88.
  • MINDBODY system rollout continues to drive growth. CEO: 'Still in very early innings' despite significant recent expansion.
  • Risks include supply chain disruptions, market saturation, currency fluctuations, and increasing competition in wellness sector.
Last Updated: 06/05/2025, 22:16
Read Full Transcript

Compare LFVN to Peers and Sector

Metrics to compare
LFVN
Peers
Sector
Relationship
P/E Ratio
18.0x1.7x12.2x
PEG Ratio
0.120.020.03
Price/Book
4.8x1.7x1.5x
Price / LTM Sales
0.7x0.3x0.9x
Upside (Analyst Target)
39.1%0.0%17.1%
Fair Value Upside
Unlock26.5%10.7%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 18.000
(+37.51% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.75%
Dividend Yield
1.38%
Industry Median 2.93%
Annualised payout
0.18
Paid quarterly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 06, 2025
EPS / Forecast
0.26 / 0.20
Revenue / Forecast
58.44M / 60.99M
EPS Revisions
Last 90 days

LFVN Income Statement

People Also Watch

37.39
EXEL
-0.85%
53.25
ALK
-1.39%
21.24
BYRN
+1.24%
25.26
CNC
+0.20%
15.16
OSCR
+5.72%

FAQ

What Stock Exchange Does Lifevantage Trade On?

Lifevantage is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Lifevantage?

The stock symbol for Lifevantage is "LFVN."

What Is the Lifevantage Market Cap?

As of today, Lifevantage market cap is 164.78M.

What Is Lifevantage's Earnings Per Share (TTM)?

The Lifevantage EPS (TTM) is 0.75.

When Is the Next Lifevantage Earnings Date?

Lifevantage will release its next earnings report on 28 Oct 2025.

From a Technical Analysis Perspective, Is LFVN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Lifevantage Stock Split?

Lifevantage has split 2 times.

How Many Employees Does Lifevantage Have?

Lifevantage has 222 employees.

What is the current trading status of Lifevantage (LFVN)?

As of 08 Aug 2025, Lifevantage (LFVN) is trading at a price of 13.09, with a previous close of 13.09. The stock has fluctuated within a day range of 12.57 to 13.21, while its 52-week range spans from 7.09 to 27.38.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.